+14 year(s) experience
Patricia joined Medtrack in 2006 as an Analyst supporting editorial content and product development. She’s now responsible for directing day-to- day content operations for Medtrack. This involves setting overall content goals by recognizing and reacting to key industry trends.
Before joining Medtrack, Patricia was a QA specialist in GLP compliance at a preclinical CRO. Earlier in her career as a cytogeneticist, she co-authored research articles for scientific journals. She holds a Bachelor of Science degree in Microbiology from Penn State University, and is certified with the American Society of Clinical Pathologists.
Patricia Writes For
Get an inside view into the trends powering COVID-era deal making in the life sciences with your free copy of “Biopharma Partnering and Financing Trends, H1 2020”. Informa Pharma Intelligence takes you inside the forces shaping the industry
Medtrack, Trialtrove, Strategic Transactions
Experts from Informa’s Medtrack, Trialtrove and Strategic Transactions teams presented a panel discussion at the recent T3 Conference in Orlando, Florida.
Partnering came into use twenty-odd years ago when pharmaceutical companies began working with biotech and increasingly sought external discovery and development opportunities.